Vanberra Signal
Free trial

SERENGEN

Curated by Signal

Developer of DNA-encoded library platform

Life Sciences Technologyserengen.com

Overview

Serengen is a developer of a novel DNA-encoded library technology. The company has developed customized DNA-encoded libraries and offers services such as chemistry development, reaction optimization and reaction scoping for production of the customized DEL. The DNA-Encoded Library Screening (DEL) are performed against an immobilized protein target.

Key facts

Founded
2019
Headquarters
Dortmund, Germany
Stage
Sign up to view
Industry
Life Sciences Technology

Business model

3 products and services
Sign up to view

Contact

Primary office
Sign up to view
Email
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • BabyFORTE

    Provider of nutritional supplements for women health

    Life Sciences TechnologyGermany

  • Paulino System

    Developer of medical device for measuring baby height

    Life Sciences TechnologyHamburg, Germany

  • Pendiq

    Developer of a smart insulin pen and needle box

    Life Sciences TechnologyMoers, Germany

About SERENGEN

What does SERENGEN do?

Serengen is a developer of a novel DNA-encoded library technology.

Where is SERENGEN headquartered?

SERENGEN is headquartered in Dortmund, Germany.

When was SERENGEN founded?

SERENGEN was founded in 2019.

Which sector is SERENGEN in?

SERENGEN operates in Life Sciences Technology.

Who are SERENGEN's competitors?

Companies similar to SERENGEN include BabyFORTE, Paulino System, and Pendiq.